In the September 1st issue of Nature (reference), scientists from the Helmholtz Zentrum Munchen Institute in Munich, Germany, the Wellcome Trust/Sanger Centre, King’s College, and Metabolon, Inc. present the most comprehensive Genome Wide Association Study (GWAS) aimed at identifying relationship between individual genetic variations and specific metabolic pathways. Using ultra-high performance LC-MS and GC-MS, the levels of over 250 metabolites, representing over 60 metabolic pathways, were analyzed in serum samples from volunteers enrolled in the German KORA F4 study (n= 1768) and in the British TwinsUK study (n= 1052). From these measures, over 37,000 metabolic traits (concentrations or ratios of metabolite pairs) were derived and their association with about 600,000 SNPs was assessed. The team identified 37 independent genetic loci with genome-wide significant associations with metabolic traits, 23 of which represented novel associations. Moreover, among these 37 genetic loci, 15 overlapped with known disease-associated genetic loci, shedding new light on possible new pathobiological mechanisms of diseases such as diabetes, kidney failure, venous thromboembolism, and coronary artery disease.
This remarkable work represents a major evolution in the field of GWAS by providing a means to place genetic information within a functional biological context. Indeed, despite identifying thousands of disease risk loci, most GWAS are cataloging exercises offering little or no information about the biological processes potentially associated with the identified genetic variants.
Thierry
Sornasse for Integrated Biomarker Strategy
No comments:
Post a Comment